Chinese medicine master Shi Qi innovatively explores the "treasure of traditional Chinese medicine" to relieve the pain of the people. Despite his 60th anniversary in the medical profession, he still adheres to clinical consultation and treatment | muscles and bones | traditional Chinese medicine

Release time:Apr 14, 2024 14:05 PM

The 6th Shixiaoshan Traumatology Academic Inheritance and Innovation Forum and the 60th Anniversary Academic Seminar of Professor Shi Qi, a renowned Chinese medicine expert, have been held today. It has been announced that the strategic agreement for the "Joint Research Laboratory of Chronic Muscle and Bone Disease Treatment and Rehabilitation" for spinal diseases has been officially signed, led by Professor Shi Qi, a renowned Chinese medicine expert, to form a series of new traditional Chinese medicine drugs and clinical plans for the diagnosis, treatment, and rehabilitation of chronic muscle and bone disease, aiming to improve the diagnosis and treatment level of chronic muscle and bone disease. Chinese medical masters Liu Jiaxiang, Sun Guangrong, and Zhang Boli delivered speeches at the seminar.

Professor Shi Qi has been practicing medicine for 60 years. He upholds the belief that "ancient people have no limits to knowledge, and when they are young and old, they start to mature. When they are young and old, they end up feeling shallow. When they know this matter, they must practice it." Even today, at the age of 80, he still insists on attending weekly consultations on the clinical front line, seeking medical advice and guidance for the people.

Exploring Traditional Chinese Medicine Therapy for Muscle and Bone Pain by Learning from Famous Schools

To preach, impart knowledge, and dispel doubts is for great doctors. Shi Qi was born into a family of traditional Chinese medicine, and his grandfather was a famous local doctor. He was influenced by traditional Chinese medicine culture from a young age and aspired to become a traditional Chinese medicine doctor. In 1957, he was admitted to the former Shanghai University of Traditional Chinese Medicine with the original intention of pursuing his dreams. Through the lectures of numerous renowned doctors at sea, he received the influence and baptism of the Shanghai style traditional Chinese medicine. In 1963, after graduating from Shiqi University, he became a disciple of Professor Shi Xiaoshan in the Department of Traumatology at Longhua Hospital. Later, he was taught by Professor Shi Youshan and gained insights into the extensive and profound nature of Shiqi's traumatology. He inherited his legacy and became the fourth generation successor of Shiqi's traumatology. From then on, he began practicing medicine and teaching for 60 years.


Chinese medicine master Shi Qi innovatively explores the "treasure of traditional Chinese medicine" to relieve the pain of the people. Despite his 60th anniversary in the medical profession, he still adheres to clinical consultation and treatment | muscles and bones | traditional Chinese medicine

In the process of aging population, chronic musculoskeletal diseases have become a health hazard. It is estimated that about 300 million people in China suffer from chronic musculoskeletal disorders. Many people think that bone and muscle disease is a modern disease, but in fact, this is a misunderstanding. Shi Qi said, "As early as 3000 years ago, there were records of bone diseases in the Book of Rites of Zhou. There were many cases of neck pain and hand numbness, such as riding horses and marching, working all day long, and emperors and generals lying down to review memorials. This precisely confirms that traditional Chinese medicine has rich experience in the treatment of orthopedics and traumatology.". The strategy of better serving the construction of a healthy China, leveraging the advantages of traditional Chinese medicine, and focusing on the diagnosis, treatment, and research of chronic musculoskeletal diseases throughout the entire process have become the exploration of Shi Qi and his team for many years.

Learn the true scriptures and apply the treasures of traditional Chinese medicine to social "big issues"

Today's seminar premiered the "Selected Works of Shi Qi's Medical Literature", which includes some medical papers, prefaces, essays, and speeches written by the team led by Shi Qi since his 60th anniversary of teaching medicine. This provides valuable reference for colleagues and young students engaged in clinical, teaching, and scientific research in traditional Chinese medicine. Few people know that Shi Qi, who initially wanted to learn traditional Chinese medicine and internal medicine, was selected by his teacher to go to the orthopedics and traumatology department due to his intelligence and strong hands-on ability after graduation.

After learning the true biography of Shi's Department of Traumatology, for 60 years, Shi Qi traveled to the doctor's field and used the method of traditional Chinese medicine syndrome differentiation and comprehensive treatment to treat countless cases of bone diseases, including various types of intervertebral disc herniation, neck and back pain, shoulder and knee pain, etc. As a renowned traditional Chinese medicine practitioner, Shi Qi's vision is not limited to treating illnesses and saving lives, but he also considers the "big issue" of balancing medical resources with social development. Surgery consumes enormous medical resources. If the treasures of traditional Chinese medicine can be promoted and widely applied, it will bring benefits to more patients. His theory has been clinically verified: Shi's "internal treatment method" stresses the internal and external use of drugs, combined with acupuncture and moxibustion, and more than 80% of patients can be cured clinically, without the need for surgery. Shi Qi also led the team to establish the "balance adjustment method", forming a muscle bone balance rehabilitation system; We have established techniques and methods with traditional Chinese medicine characteristics and advantages, such as "Shi's Twelve Character Health Preservation Technique", "Spinal Balance Exercise", "Muscle and Bone Balance Exercise", and "Three Steps and Nine Methods for Neck Treatment", which have been promoted both domestically and internationally.


Chinese medicine master Shi Qi innovatively explores the "treasure of traditional Chinese medicine" to relieve the pain of the people. Despite his 60th anniversary in the medical profession, he still adheres to clinical consultation and treatment | muscles and bones | traditional Chinese medicine

Teaching and educating, cultivating more than 400 high-level students all over the world

Inheriting the essence and keeping integrity and innovation are the principles of the inheritance and development of traditional Chinese medicine. Seven years ago, when his alma mater Shanghai University of Traditional Chinese Medicine was established 60 years ago, Shi Qi, as the former president, donated 60000 yuan from his own pocket. "When I stepped into the school, the student handbook wrote - 'Cultivate advanced traditional Chinese medicine practitioners with socialist consciousness and wholeheartedly serve the people.' Many years have passed, and this sentence is still outdated to this day." He urged himself in this way, and even more so inspired his students.

After more than 30 years of hard work, the orthopedic discipline team led by Shi Qi has become a national key discipline, and has trained and guided more than 400 master's, doctoral, postdoctoral, and apprentices. The disciples are distributed in 25 provinces and cities across the country and overseas, and have become the leader of traditional Chinese medicine orthopedic science in China. Their academic achievements are also well-known in Xinglin. Now, the orthopedic department team has transformed Longhua Hospital's orthopedic department into a clinical highland with distinctive features in Shixiaoshan's orthopedic department. It has built an innovative research platform for traditional Chinese medicine that is deeply integrated with modern technology and competitive nationwide. It is also a cradle for cultivating high-end talents in traditional Chinese medicine in the new era, continuously contributing more talents to the traditional Chinese medicine industry.

It is reported that today's seminar will be divided into special forums such as the "Shixiaoshan Traumatology Academic Alliance Discussion and Exchange Meeting", "Shiqi National Medical Master Academic Thought Exchange Meeting", and "Traditional Chinese Medicine Phenomics and Precision Medicine Exchange Meeting". Dozens of well-known domestic and foreign experts and scholars from well-known universities and research institutions such as Tsinghua University, Peking University, Shanghai Jiao Tong University, Zhejiang University, Fudan University, The Chinese University of Hong Kong, and Sichuan University, as well as sister universities from Guangdong, Jiangsu, Gansu, Jiangxi, Beijing, Shanghai, Tianjin, Chengdu, and other regions, as well as the construction unit of the Shixiaoshan Traumatology Academic Alliance, brought wonderful and diverse lectures to the attendees.


Chinese medicine master Shi Qi innovatively explores the "treasure of traditional Chinese medicine" to relieve the pain of the people. Despite his 60th anniversary in the medical profession, he still adheres to clinical consultation and treatment | muscles and bones | traditional Chinese medicine
Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer
Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer

Immunotherapy has been proven to achieve significant therapeutic effects in various solid tumors. However, for pancreatic cancer, known as the "king of cancer", immunotherapy has been ineffective. On August 4, Professor Yu Xianjun, Dean of the Cancer Hospital Affiliated to Fudan University, and Shi Si, Associate Professor of Pancreatic Surgery released a research achievement, which first found the key role of cysteine rich protein 1 in shaping the immunosuppressive microenvironment of pancreatic cancer, filled the gap in the research field of immunosuppressive microenvironment of pancreatic cancer, and provided a theoretical basis for precise immunotherapy of pancreatic cancer patients. Ductal adenocarcinoma of the pancreas is the main type of pancreatic cancer, accounting for about 90% of all pancreatic cancer. Due to its high malignancy and poor treatment effectiveness, pancreatic ductal adenocarcinoma has always been one of the most malignant tumors. In recent years, the level of surgical techniques and comprehensive treatment has been achieved

A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare
A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare

A 14-year-old girl has been experiencing symptoms such as protruding pupils, incomplete eye closure, corneal injury, restricted eye movement, and overall fatigue for several years. The physical discomfort and facial abnormalities caused by eye diseases have made her increasingly reticent, and her temperament is vastly different from before. At the Ophthalmology Department of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the pupil has been diagnosed with a rare thyroid ophthalmopathy combined with myasthenia gravis, which requires prompt treatment. However, considering the young age of the pupil, conventional hormone and radiation therapy cannot be used. Therefore, Zhou Huifang, Deputy Director of Ophthalmology and thyroid ophthalmology expert, has developed a targeted drug combined with surgical treatment plan for it, and targeted drug treatment will be performed first. Three months ago, I was hospitalized for one week with mydriasis and received intravenous targeted drug treatment. Afterwards, I went home for observation and followed up on time

The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease
The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease

According to the Statistics of Chinese Dry Eye Expert Consensus, the incidence rate of dry eye in China is about 21%~30%, and it is estimated that there are at least 300 million patients nationwide. The Dry Eye Diagnosis and Treatment Studio of Shanghai Eye Disease Prevention and Treatment Center was officially launched today. In the future, the studio will continuously improve the dry eye diagnosis and treatment standards, and form standardized diagnosis and treatment concepts and service models. Suitable technologies will be promoted to the community, allowing residents to enjoy convenient dry eye diagnosis and treatment services at their doorstep. Executive Dean and Party Secretary Gao Wei stated that this is also one of the livelihood service measures recently launched by the hospital around high-quality development and meeting the needs of the people. It is reported that dry eye syndrome is a chronic ocular surface disease caused by multiple factors. The instability of the tear film or imbalance of the ocular surface microenvironment caused by abnormal quality, quantity, and dynamics of tears can be accompanied by ocular surface inflammatory reactions, tissue damage, and nerve abnormalities, resulting in various discomforts in the eyes

The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice
The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice

The International Dental Implant Consensus Report, jointly written by the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and renowned universities in the field of dentistry such as Harvard University, University of Zurich, University of Gothenburg, Columbia University, and University of Frankfurt, has recently been jointly published in top journals in the field of dentistry, including Clinical Periodontology and Clinical Dental Implant Research. This consensus has for the first time established an internationally unified core set of indicators for evaluating the clinical effectiveness of dental implants, covering the five key areas of the field of dental implants. It is of milestone significance for carrying out standardized clinical diagnosis, treatment, and research on dental implants. The core evaluation indicators determined by this consensus will become an important benchmark for scholars in the field of dental implants worldwide to conduct high-quality research. The consensus is composed of 8 top international experts in the field of oral implantation

Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases
Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases

Recently, Catherine, a British girl born in the 1990s, received autologous peripheral blood hematopoietic stem cell transfusion at the Cancer Center of Shanghai Jiahui International Hospital, and was successfully discharged from the warehouse. She is now on her way back to China after being discharged from the hospital. She is also the first patient at Shanghai Jiahui International Hospital to complete relevant treatments. In 2019, Catherine was diagnosed with Hodgkin's lymphoma in the UK, and after treatment, the disease completely improved. During her work and life in China in 2021, she went to seek medical attention due to multiple enlarged lymph nodes. Pathological biopsy confirmed a recurrence of Hodgkin's lymphoma, and through combined targeted drug treatment, her condition was temporarily under control. Last year in the second half of the year, when the disease recurred, the girl began to use immunotherapy combined with targeted drugs for treatment. Expert evaluation suggests that for young patients with hematological tumors, the risk of recurrence is high and treatment difficulty is increasing in the future. Autologous hematopoietic stem cell therapy is recommended